# T cell equation as a conceptual model of T cell responses for maximizing the efficacy of cancer immunotherapy

Preprint · Haidong Dong, Yiyi Yan, Roxana S. Dronca, Svetomir N. Markovic

- Archive id: arxiv:1510.08372
- Published: 2015-10-28
- Venue: SOJ Immunol 5(1):1-5, 2017
- DOI: https://doi.org/10.15226/2372-0948/4/1/00155
- arXiv: https://arxiv.org/abs/1510.08372
- Citations: 0
- Source URL: https://arxiv.org/abs/1510.08372
- PDF: https://arxiv.org/pdf/1510.08372
- Provenance: arxiv

## Abstract

Following antigen stimulation, the net outcomes of a T cell response are shaped by integrated signals from both positive co-stimulatory and negative regulatory molecules. Recently, the blockade of negative regulatory molecules (i.e. immune checkpoint signals) demonstrates therapeutic effects in treatment of human cancer, but only in a fraction of cancer patients. Since this therapy is aimed to enhance T cell responses to cancers, here we devised a conceptual model by integrating both positive and negative signals in addition to antigen stimulation. A digital range of adjustment of each signal is formulated in our model for prediction of a final T cell response. This model allows us to evaluate strategies in order to enhance antitumor T cell responses. Our model provides a rational combination strategy for maximizing the therapeutic effects of cancer immunotherapy.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.